Astellas Pharma, Inc
Represented client in collaboration agreement with Maxygen, and in a $4 billion hostile takeover of OSI Pharmaceuticals.
De Novo Ventures
Represented client in financing of Articulinx, MyoScience, Simpirica Spine, Synergeyes, TearScience.
InterWest Partners
Represented client in financings of Integrated Diagnostics and Restoration Robotics.
Kleiner Perkins Caufield & Byers
Represented client in financing of GreatPoint Energy, Inspire, Invuity, and OtisMed.
Mentor Corporation
Represented client in a $1 billion acquisition by Johnson & Johnson.
NEA
Represented client in financing of Cardioxyl Pharmaceuticals.
NeurogesX
Represented client in commercialization agreement with Astellas, and in a royalty agreement with Cowen Healthcare Royalty Partners.
New Leaf Venture Partners
Represented client in financing of Glumetrics.
Paul Capital Healthcare
Represented client in royalty financing agreement with Vernalis.
Paul Capital Venture
Represented client in revenue interest agreement with SpePharm.
Thomas Weisel
Represented client in financing with Hansen Medical.
Venrock
Represented client in financing of Zeltiq Aesthetics and Intuity Medical.